Genetic Research illuminates Autism‘s Complex Origins

Scientists are increasingly focused on ⁣the genetic components of autism, working to understand which genes are involved adn how their ⁤expression‍ is influenced by various factors.

Unraveling Genetic Variations

Decades ⁢after initial twin studies highlighted the role of genetics in autism, researchers are still uncovering the intricate relationship between the condition and the human genome.

The genetic variation between⁢ individuals is‌ minimal, around 0.1%, meaning⁤ that roughly one in every 1,000 DNA⁣ base pairs differs. Thomas Bourgeron, a professor of neuroscience at⁢ the Institut Pasteur in Paris, notes that some ‌of these variations have no effect, while others have⁤ a small or very strong impact.

To date, “super strong” variations have been identified in⁢ nearly⁢ 20% of‌ autism cases. These involve a single⁢ mutation in‌ a single gene that significantly contributes to neurodevelopmental differences. Research is ‍heavily focused on these monogenic mutations, as ‌they often lead to severe disabilities​ that can limit⁤ life expectancy, according​ to Bourgeron.

Bourgeron emphasizes that these cases are not representative of all autism. Individuals ​with these major genetic changes are likely to experience intellectual impairment, motor delays, or epileptic encephalopathy, significantly impacting their quality of​ life and their families.

Scientists have ​identified at least 100 genes where these⁣ mutations can occur.In 2003, ​Bourgeron identified two genetic mutations ⁤linked to autism, both affecting proteins involved ‌in synaptogenesis, the formation of connections between⁣ neurons in the brain.This discovery, though initially overshadowed by other news ⁤events, marked a notable advance.

further research has revealed mutations in the​ Shank3 gene, estimated to occur in less than ​1% of ‌autistic individuals.Some of these changes are “de novo” variants, meaning⁣ they arise spontaneously ‍in a developing embryo and are not present in the parents’ DNA. These de novo variants are considered rare and unexpected, according to researchers.

However, in other instances, these genetic changes may ‍be inherited‍ from a parent who appears ⁢neurotypical. This phenomenon is more complex and has ​only ​recently‍ begun to be understood.

Daniel Geschwind notes that a parent carrying a rare genetic mutation may not be affected⁤ as ‍the mutation alone is insufficient to⁤ cause autism. Though,‍ in their child, this major genetic mutation may combine with other genetic variants, each‌ having a smaller individual impact, leading to neurodevelopmental differences.

Environmental factors are also believed to play ‌a role in the ⁤growth of autism. Even among identical twins, if one is diagnosed with autism, there is a 10%‌ chance the other will not be.

Historically, the search for environmental factors has led to debunked theories, such as‍ the claim⁣ that certain vaccines‌ cause autism.⁤ While research ​continues, the American National Institute of Health (NIH) identifies potential non-genetic causes, including prenatal exposure to air pollution and certain pesticides, extreme prematurity, and birth complications resulting in oxygen deprivation‍ to the baby’s brain.

Understanding Early Neurological Development

Genetic research is providing ​insights into how neurological ‌development can⁢ lead to autism. ⁤Many of the genes ⁤implicated in autism⁢ become functional during the formation ​of the cortex, the brain’s outer ​layer responsible for memory, problem-solving, and thought.

This critical period of brain development occurs in the fetus, peaking between 12 and 24 weeks of gestation, according to Geschwind. Mutations during this time​ can ​disrupt normal development patterns, diverting the brain’s trajectory away from typical neurodevelopment.

The identification of these genetic changes ​has enabled parents to form support groups, such as the Familiescn2a Foundation, for families of autistic⁢ children⁤ with a genetic ‍change in the SCN2A gene.The use of this genetic details to‍ inform future reproductive decisions is also being discussed.

Geschwind explains that if a genetic variant is de novo, parents can be informed that the risk of having another child with the ⁤same neurodevelopmental issues is low, as hereditary factors are limited. Families can also gain insights into the potential developmental⁢ trajectory of their child.

While genetic research offers significant ​benefits, it is indeed not universally embraced by the autistic community. autism is a broad spectrum, ranging from individuals with severe physical and mental disabilities requiring extensive support to‍ those ​with milder needs who ⁤view their autism as an integral part of their identity and‌ an advantage, and who oppose ‌the portrayal of autism as a disorder.

Autism Research Focuses on⁢ Genetic⁢ Links, Emotional Recognition

Researchers ⁢are delving deeper into the⁤ genetic underpinnings of autism spectrum disorder (ASD), exploring how genes influence social interaction, empathy, and even cognitive​ strengths. A key area of examination involves understanding how ‍individuals with autism process and interpret emotions, particularly through facial cues.

The ‘Reading the Mind in the Eyes’ Test

One tool used in ⁢this research is the “Reading the Mind in the Eyes” test, developed by scientists at the University of Cambridge. The test assesses an individual’s ability to recognize emotions like playfulness, comfort, irritation, or boredom based solely on photographs of a person’s eyes.

according to Bourgeron, some research suggests that individuals with autism may process facial information differently. ⁤ “Autistic people have a different way of looking at the face and seem to‍ get more information from the person’s mouth,” Bourgeron said.”Neurotypical people get more⁣ information from their eyes.”

Genetic Data and⁣ Emotion Recognition

In a large-scale study, researchers partnered with the DNA testing service 23andMe to collect data from over 88,000‍ individuals. Participants completed the “Reading the mind in the Eyes”‍ test, and their performance was compared with their genetic information. This allowed scientists to identify genetic variants associated ‌with ⁣lower emotion recognition⁢ abilities, many of which are believed to be more common in people with autism.

Studies have indicated that common genetic variations linked to ⁤autism often show a negative correlation with empathy and‌ social communication skills. Conversely, these same variants are often positively correlated with abilities⁣ in analyzing⁢ and building systems, and also adherence to rules and routines.

Intriguingly, these genetic links have also been associated with higher levels of education ⁤and enhanced spatial, mathematical, or artistic skills.Geschwind noted‌ that this might explain why these genetic variants, present in human ancestors, have persisted throughout history.

Sex Differences in Autism

Geschwind and Baron-Cohen are now investigating weather some of the ⁢common genetic variants associated with autism might explain the‍ higher prevalence of autism in men and why autistic women ‌may be more adept at masking their neurodivergent traits.

Geschwind suggests that differences in the development and functioning of male and female brains may play a role. “It is ⁢indeed likely that the ‌differences in development and ⁢functioning of male and female brains make‍ men more sensitive and protect women from genetic ​susceptibility to autism to some measurable degree, but we do not yet understand that,” said Geschwind.

Some experts believe that autism may be underdiagnosed in women and that their ⁤experiences are often overlooked.

Treatment vs. Identity

The research into the⁣ genetic basis ‌of autism has​ sparked debate within the autism community.While some ​scientists are focused on developing treatments, others, including some autistic individuals, view autism as an integral part of their identity and a shared ‍experience, not a disorder to be cured.

Sue fletcher-Watson, professor of developmental psychology at ‍the University of Edinburgh, argues that autism is ‍not a biological phenomenon ⁤that can be definitively tested and categorized. “Autism is not a biological phenomenon⁤ which must be tested and for which we obtain ‍a categorical result or prognosis,” explains Sue ⁣Fletcher-Watson.‍ “It is not something,​ like cancer, which is universally recognized ⁣as bad and for which everyone ⁣wants a⁤ remedy. In my opinion, this will never be the case. ”

Fletcher-Watson also raises concerns about the potential for genetic research to lead to prenatal testing for autism, which some fear could be used for⁣ eugenic purposes. She argues that researchers have⁤ not adequately addressed the autistic community’s concerns about the security‍ and future use of genetic data.

She points to the established ​practice of prenatal testing for conditions ⁢like Down syndrome in some countries, where pregnancy termination rates after‌ positive screening are​ high.

The⁤ Spectrum of Autism

Joseph Buxbaum, professor of psychiatry at the Icahn School of Medicine at Mount Sinai, emphasizes the wide‌ range of experiences within the autism ⁢spectrum. He ⁣argues that research should focus on those with more severe challenges.

When someone says to me: “I am autistic and I do not think that I‌ have to be the ⁢subject of research”, I answer them: “What about someone who does not speak, who has a Qi of 50 and who will never be able to live alone and ‌without supervision? ⁣”What do‌ you think of this person?” Thus, when I think of interventions, I think ⁤of these people, as opposed to someone who has difficulty​ maintaining visual contact, who has unusual interests and who has​ conflicts in social situations ”.

Geschwind echoes this sentiment, highlighting the need to differentiate between ⁣individuals with varying​ levels of support needs. He suggests that while some individuals with autism may benefit from treatment, others may simply⁤ require understanding and accommodation.

The Lancet Commission officially recognized the term ⁣”deep autism” in 2021‌ to describe individuals with profound disabilities who require 24-hour support. Clinical trials are underway to explore therapeutic strategies targeting specific genes associated ‌with physical and intellectual disabilities in individuals with deep autism.

Potential Treatments

One approach to⁣ treatment‌ focuses on strengthening the function of the unaffected copy ​of‌ a gene when the other copy is ⁣mutated. Geschwind’s lab is exploring ‌this strategy, suggesting that increasing the activity of the functional copy⁤ could compensate for the loss of function ​in the mutated copy.

Bourgeron has conducted a clinical trial using lithium‌ to stimulate ⁤a version of the Shank3 gene in children with mutations in that gene. ⁣geschwind suggests that gene editing technologies like CRISPR could perhaps be used​ to intervene even earlier in⁢ life, potentially administering gene therapy‌ to babies in utero.

The FDA has authorized​ Jaguar Gene Therapy to conduct⁣ a clinical trial of gene therapy in​ autistic children with a‍ Shank3 gene mutation and Phelan-McDermid syndrome.

“This test is⁤ only possible as all participating children have been the subject of ⁣a genetic diagnosis,” ‌explains Mr. Buxbaum. “And because Mount Sinai researchers and have spent the last 15 years ⁢studying the evolution​ of these children when they are carrying these

Genetic Research Offers New ​Avenues⁢ for Understanding Autism

⁣ ⁣ ⁤ Researchers are increasingly focusing on the genetic ⁤components of autism spectrum disorder (ASD), exploring⁢ how​ specific genes and genetic variations contribute to the condition’s diverse manifestations. This research aims not ​only to identify risk factors but also to develop targeted treatments and support systems for individuals with ⁢autism.

Unlocking Autism’s Genetic Secrets

Recent studies highlight the potential⁤ of polygenic scores (PGS) and the impact ‌of rare ⁣genetic variants, such as copy number ​variations (CNVs) and single nucleotide gene-disrupting variants, in predicting⁢ cognitive and adaptive ‌behaviors in autistic children. While strong statistical links have been identified, further research is needed ​to fully understand these complex ⁤relationships.

Divergent Views on​ Autism Therapies

While some experts believe that clinical trials focused on genetic interventions could greatly ⁤benefit children with autism and their families, others express reservations. One outlook suggests⁢ that some interventions might be more accurately classified as treatments for intellectual disability rather than autism-specific therapies.

⁤ According to Ms. Fletcher-Watson,some⁣ claims regarding “unique​ gene autism” may lack sincerity. She argues that while funding ‍and resources are readily available for autism research, similar ⁣support is frequently enough lacking ​for intellectual disability research, ⁤even though the two conditions can overlap.

Hope for Treating Co-occurring Conditions

Fletcher-Watson is optimistic about the potential for genetic research​ to lead to ⁣new treatments for conditions frequently diagnosed alongside autism, including epilepsy, sleep disorders, obsessive-compulsive disorder (OCD), and gastrointestinal issues.

European Project Focuses on Risk‍ and Resilience

Mr. Bourgeron ​is leading a‍ European project examining⁣ risk factors, resilience, and developmental diversity within mental health. This project involves collaboration with autistic individuals and their families to gain a deeper ‌understanding of why autism rarely occurs in isolation and what factors predispose individuals to related disorders.
‍

Recognizing Neurodiversity

Bourgeron emphasizes the importance of​ recognizing neurodiversity and reducing the stigma associated with autism. He advocates for a personalized approach to care, acknowledging that the needs of autistic individuals vary significantly.

“I⁣ think that as geneticists, we must return to the needs of each person,” Bourgeron said. “Some autistic people with the Shank3 transfer are so seriously affected that they need care 24 hours a‍ day, while others only⁤ need specific care. Others only need specific support for school.”
⁢ ⁤

Bourgeron added ​that society should strive to create an inclusive environment where individuals with diverse neurological profiles can thrive.

“In general, we must better recognize neurodiversity and do our best so that people who work differently from the‍ majority can flourish in our societies.”
​

Genetic Research Illuminates Autism’s Complex Origins

Scientists are increasingly focused on the genetic⁣ components‌ of autism, working to understand which genes are ‍involved and how their expression is influenced‌ by various factors.

Unraveling‍ Genetic Variations

Decades after initial twin studies highlighted the role of genetics in autism, researchers are still uncovering the intricate relationship ⁣between the condition and the human ​genome.

The genetic variation between individuals is minimal,around 0.1%,meaning that roughly one in every 1,000 DNA ‍base pairs⁣ differs. Thomas Bourgeron,a professor⁢ of neuroscience at ⁣the Institut Pasteur in Paris,notes that some of these variations have no effect,while⁢ others⁣ have a small or very strong impact.

To date, ‌”super strong”‌ variations have been identified in nearly 20% of autism cases. ‍These involve a single ​mutation in a single ​gene that considerably contributes to neurodevelopmental‌ differences. Research is heavily focused on these monogenic mutations,as they often lead to severe⁤ disabilities ⁣that can​ limit life ‌expectancy,according to‌ Bourgeron.

Bourgeron emphasizes that these cases are not representative of all‌ autism. Individuals with‌ these major​ genetic changes ⁣are ​likely to experience intellectual impairment,motor delays,or epileptic encephalopathy,significantly impacting their quality of ‍life⁢ and their families.

Scientists have identified at ‌least ​100 genes​ where these mutations can⁢ occur. In ⁣2003, Bourgeron identified two genetic⁣ mutations linked to autism, both affecting proteins involved in synaptogenesis, the formation of connections between​ neurons in the brain. This discovery, though initially overshadowed by othre news events, marked⁢ a notable advance.

Further research has​ revealed mutations in the‌ Shank3‌ gene,⁤ estimated ⁤to occur in less than 1% of‍ autistic individuals. Some of these​ changes are “de novo” ‍variants,meaning ⁢they arise spontaneously⁢ in a ⁤developing embryo and are not present in the parents’ DNA. These⁢ de novo⁣ variants are considered rare and unexpected, according to researchers.

However, in other‌ instances, these ​genetic changes may be⁤ inherited from a parent who appears neurotypical. ⁢This⁢ phenomenon is more complex and has only ⁢recently begun ‌to be understood.

Daniel Geschwind notes that a parent carrying a rare genetic mutation may ​not be affected as ⁤the mutation alone ‍is⁢ insufficient to cause autism. Though, in‍ their ⁣child,‌ this major ‌genetic mutation⁣ may combine‍ with ‍other genetic ‌variants, each ​having a smaller ‌individual⁢ impact, leading ⁣to ⁢neurodevelopmental differences.

Environmental factors are also believed to play a role in the growth‍ of autism. Even among identical twins, if one ‍is diagnosed with autism, there is ⁤a 10% chance the other will⁣ not be.

Historically, the search for environmental factors has led‍ to debunked⁤ theories, such as the claim​ that⁤ certain vaccines cause autism. While research continues, the American National Institute of Health (NIH) identifies‍ potential non-genetic causes, including prenatal exposure to ⁣air‌ pollution and ‌certain pesticides, extreme prematurity, and birth complications resulting in oxygen⁤ deprivation‍ to the baby’s brain.

Understanding Early Neurological Development

Genetic research is⁢ providing insights into ‍how neurological development ‌can lead to autism.Many of the ​genes implicated in⁢ autism become functional during the⁤ formation of the ‌cortex, the brain’s outer layer responsible for ‍memory, problem-solving, and thought.

This critical period of brain‌ development occurs⁤ in‍ the fetus, peaking between 12 and ⁢24 weeks of ⁢gestation, according​ to Geschwind.⁤ Mutations during this time can disrupt normal ⁣development patterns, diverting the brain’s trajectory away from typical neurodevelopment.

The identification of ‍these genetic changes has ​enabled parents‌ to form‌ support groups,‌ such as the‌ Familiescn2a Foundation, for families of ​autistic⁤ children ⁢with a⁤ genetic change in the SCN2A ​gene. ⁢The use of this genetic details to inform future reproductive decisions ​is also being discussed.

Geschwind explains that if a genetic variant is de novo, parents can be informed that the risk of having ‍another‌ child with ​the same neurodevelopmental issues is low, as hereditary⁣ factors are limited. Families can also ⁢gain insights into the potential ​developmental trajectory of‌ their ⁢child.

While genetic research offers important benefits, ​it ​is‍ indeed not universally embraced by the autistic community.‍ Autism ‍is a broad spectrum, ranging from individuals with⁣ severe physical and ⁤mental disabilities requiring extensive support to those with milder needs who ​view their ⁢autism as an integral part of their identity and an⁢ advantage, and who oppose the ‍portrayal of autism as a ⁢disorder.

autism Research Focuses on Genetic Links, Emotional Recognition

Researchers⁢ are delving deeper ​into the genetic underpinnings⁤ of autism spectrum disorder (ASD), exploring how‌ genes influence social ​interaction, empathy, ⁤and even cognitive strengths. A key ‌area of‍ examination involves understanding how individuals with autism process and interpret emotions,especially through facial cues.

The ‘Reading the Mind in the Eyes’ Test

one ⁢tool used‌ in this research is the “Reading the mind in the Eyes” test, developed by scientists at‍ the University of Cambridge. The test assesses an individual’s ability to recognize emotions like⁣ playfulness,comfort,irritation,or boredom based solely on photographs of a ‌person’s eyes.

According to Bourgeron, some research suggests that ⁢individuals with autism may process ‌facial information differently.⁤ “Autistic ⁣people have a different way of looking at the ‍face and ​seem⁣ to ⁤get more⁣ information from​ the person’s mouth,” Bourgeron said. “Neurotypical people get‍ more information ‍from ⁢their eyes.”

Genetic Data​ and Emotion Recognition

In⁣ a large-scale study, researchers partnered with⁣ the DNA testing service 23andMe to collect data from over 88,000 individuals. Participants completed the “Reading the mind in the Eyes” test, and⁤ their performance was compared ⁤with ‌their genetic information. This‌ allowed ​scientists to identify genetic variants associated with lower emotion recognition abilities, many of which⁣ are believed to be⁣ more common in people with autism.

Studies have indicated ⁤that common ‍genetic variations linked to autism​ often show a negative correlation‌ with empathy and social dialog skills. Conversely, these same ‍variants are often ​positively correlated with abilities in analyzing and building systems, ⁣and also adherence to rules and⁢ routines.

Intriguingly, these genetic links have‍ also been associated with ⁣higher levels of education and enhanced spatial, mathematical, ‍or artistic skills. Geschwind noted that⁤ this ‍might explain ⁣why these genetic variants, present⁢ in human ancestors, have persisted throughout history.

Sex Differences ⁣in Autism

Geschwind and Baron-Cohen are now ⁢investigating whether some of the⁤ common genetic variants associated with autism might explain the‌ higher prevalence ‌of autism in men and why ⁤autistic‍ women may be more adept at masking their‍ neurodivergent traits.

Geschwind suggests that differences in the development and functioning of male ⁤and female brains may play ⁣a role. “it​ is indeed ‍indeed likely that the differences in development and functioning of ‌male and female brains make men more‍ sensitive and​ protect women ‌from genetic susceptibility to‌ autism to some measurable ​degree, but we ⁢do not yet understand that,” said Geschwind.

Some experts‌ beleive that autism may be underdiagnosed in women ⁢and that⁢ their experiences are⁤ often overlooked.

Treatment ​vs. ​Identity

The⁢ research into the genetic basis⁣ of autism has sparked⁢ debate within the autism community. While some scientists are focused on developing​ treatments, others, including some autistic​ individuals, ​view autism as an integral part of their ‌identity‌ and a shared experience, not a disorder to be cured.

Sue Fletcher-Watson, professor of developmental psychology at the⁤ University of Edinburgh, argues​ that autism is not⁣ a biological phenomenon that can be definitively tested and categorized. “Autism⁤ is​ not a biological phenomenon which must be tested and for⁤ which we obtain⁢ a categorical result or prognosis,” explains Sue Fletcher-Watson. “It is indeed not something, like cancer, which is universally recognized⁤ as bad and for which everyone wants a ‌remedy. In my opinion,this will never be the ⁤case.”

Fletcher-Watson also raises concerns about the potential for genetic research to lead to prenatal testing for ⁢autism, which some fear ⁣could be used‌ for eugenic​ purposes. She argues that researchers have ‍not adequately addressed the autistic community’s concerns about the security and future use of genetic data.

She points to the established practice of ‍prenatal testing for conditions like Down syndrome in some⁤ countries, where pregnancy termination ⁣rates after positive screening are ​high.

The Spectrum of⁢ Autism

Joseph Buxbaum, professor of psychiatry at the Icahn School‌ of Medicine at Mount Sinai, emphasizes the wide range of experiences within the autism spectrum. He argues ⁣that research ⁣shoudl focus on those with⁤ more severe challenges.

When ‍someone says to ‍me: “I am autistic and I‍ do not think that ‍I ⁤have to be the subject ⁢of research”, I‌ answer them: “What​ about ⁤someone who does ⁤not‍ speak, who has a‍ Qi of 50 and who will never be able to live alone and without‌ supervision?⁢ What do you think ​of this person?” Thus, when I think of interventions, I think of these people, as opposed to someone who has difficulty maintaining visual ‍contact, who ​has unusual interests ‌and⁢ who has conflicts in⁢ social situations.”

Geschwind echoes this sentiment, highlighting⁤ the need to⁢ differentiate between individuals ⁢with varying ⁢levels of support ⁢needs. He suggests that while some individuals with autism may benefit from treatment, others may simply require understanding‌ and accommodation.

The Lancet Commission officially recognized the term “deep autism” in 2021 to describe individuals with profound disabilities who require 24-hour support. Clinical trials are underway to explore therapeutic strategies targeting specific genes ‌associated​ with ⁣physical and intellectual disabilities ⁣in individuals ⁢with deep‍ autism.

Potential Treatments

One approach‌ to treatment ‌focuses‍ on strengthening the function of the unaffected copy of⁢ a gene when the other copy is mutated.Geschwind’s lab is exploring this strategy, suggesting‌ that increasing the activity of the ​functional copy could compensate for‍ the loss of ⁣function in the ⁤mutated copy.

Bourgeron has conducted a ⁤clinical trial using lithium to stimulate a version ​of ‌the ⁤Shank3 gene⁣ in children with mutations in that gene. Geschwind suggests that gene editing technologies like CRISPR​ could perhaps be used to intervene even earlier in life, perhaps administering gene therapy to⁢ babies in utero.

The FDA has authorized jaguar Gene Therapy‌ to conduct a clinical⁢ trial of⁤ gene therapy in autistic children with a Shank3 gene mutation and Phelan-McDermid syndrome.

“This test is only possible as all participating children have been ‍the subject of⁣ a genetic ⁣diagnosis,” explains Mr. Buxbaum. “And as Mount‌ Sinai researchers and have spent the last 15 years studying the evolution of these children when they are carrying these⁣

Genetic⁣ Research Offers New ⁢Avenues for Understanding ​Autism

Researchers are increasingly focusing on the ​genetic components of autism spectrum disorder ⁢(ASD), exploring how specific genes and genetic ‌variations‌ contribute to​ the condition’s diverse manifestations. This research aims not only to identify risk factors but also to develop‍ targeted treatments and support⁤ systems for individuals ​with autism.

Unlocking autism’s‌ Genetic Secrets

Recent ⁤studies highlight the potential of polygenic‌ scores (PGS) and the impact of rare genetic⁣ variants, such as⁣ copy number ​variations (CNVs) and single ⁤nucleotide gene-disrupting variants, in ‍predicting cognitive and adaptive behaviors in autistic children. While ⁣strong​ statistical links have been identified,​ further research is needed to⁣ fully understand these complex relationships.

Divergent Views​ on Autism​ Therapies

While‍ some experts believe that clinical trials focused on⁣ genetic interventions could greatly benefit children with autism and⁤ their families, others express reservations. One outlook suggests that some interventions might be more accurately classified as treatments ‌for intellectual disability rather ‌than autism-specific therapies.

According to Ms. Fletcher-Watson, some claims ⁤regarding “unique gene ⁣autism” may lack sincerity. She argues that while funding and resources are readily available ‌for autism‍ research, similar support ‌is frequently lacking for intellectual disability​ research, even though the two ⁢conditions can overlap.

hope‌ for‌ Treating Co-occurring⁣ Conditions

Fletcher-Watson is optimistic‌ about the potential for‍ genetic research to lead to new treatments for ‌conditions frequently diagnosed‍ alongside⁣ autism, including ‍epilepsy, sleep disorders, obsessive-compulsive disorder (OCD), and gastrointestinal issues.

European project Focuses on Risk and Resilience

Mr.⁤ Bourgeron is leading a European⁢ project examining risk factors, resilience, and developmental diversity within⁣ mental health. This project ‌involves ​collaboration with autistic individuals ⁢and their families to gain a deeper understanding of why ​autism‌ rarely occurs‍ in isolation and‌ what factors predispose individuals‌ to⁢ related disorders.

Recognizing Neurodiversity

Bourgeron emphasizes the importance of recognizing neurodiversity and reducing the stigma associated⁢ with autism. he advocates for a personalized approach to care, acknowledging⁣ that the needs of autistic individuals vary significantly.

⁢ ‌ ⁢ “I think that as geneticists, we must return ⁢to the needs of each person,” Bourgeron said. “Some autistic people with the Shank3 transfer are so seriously affected that they need care‌ 24 hours a day,‌ while others only need specific‍ care. Others only need⁤ specific support for school.”

Bourgeron added that society ⁣should ⁤strive ​to create an inclusive habitat where ‍individuals⁤ with ⁢diverse neurological profiles can thrive.

“In general,​ we must ⁣better recognize⁢ neurodiversity and ⁢do our best ‌so ‌that people who work​ differently​ from ​the majority can flourish in our societies.”